Molecular and cellular effects of oncogene cooperation in a genetically accurate AML mouse model.

Molecular and cellular effects of oncogene cooperation in a genetically accurate AML mouse model.

Show other versions (1)

Biallelic CEBPA mutations and FMS-like tyrosine kinase receptor 3 (FLT3) length mutations are frequently identified in human acute myeloid leukemia (AML) with normal cytogenetics. However, the molecular and cellular mechanisms of oncogene cooperation remain unclear because of a lack of disease model...

ver descrição completa

Detalhes bibliográficos
Main Authors:	Reckzeh, K, Bereshchenko, O, Mead, A, Rehn, M, Kharazi, S, Jacobsen, SE, Nerlov, C, Cammenga, J
Formato:	Journal article
Idioma:	English
Publicado em:	2012

Registos relacionados

Molecular and cellular effects of oncogene cooperation in a genetically accurate AML mouse model.
Por: Reckzeh, K, et al.
Publicado em: (2012)

ROLE OF BIALLELIC C/EBPALPHA MUTATIONS AND FLT-3 ITD IN INITIATION AND MAINTENANCE OF AML
Por: Reckzeh, K, et al.
Publicado em: (2010)

Hematopoietic stem cell expansion precedes the generation of committed myeloid leukemia-initiating cells in C/EBPalpha mutant AML.
Por: Bereshchenko, O, et al.
Publicado em: (2009)

MEIS2 Is an Oncogenic Partner in AML1-ETO-Positive AML
Por: Naidu M. Vegi, et al.
Publicado em: (2016-07-01)

Germline counterparts of oncogenic mutations: who gives a JAK?.
Por: Mead, A, et al.
Publicado em: (2013)

Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferation.
Por: Kharazi, S, et al.
Publicado em: (2011)

Insights into specificity, redundancy and new cellular functions of C/EBPa and C/EBPb transcription factors through interactome network analysis
Por: Cirilli, M, et al.
Publicado em: (2016)

Oncogenic Roles Of A Histone Methyltransferase SETDB2 In AML1-ETO Positive AML
Por: Mu G, et al.
Publicado em: (2020-02-01)

New dual inducible cellular model to investigate temporal control of oncogenic cooperating genes
Por: Matthew R. Kent, et al.
Publicado em: (2024-09-01)

S128: AML CONDITIONING OF THE BONE MARROW MICROENVIRONMENT THROUGH CCR1 LIGAND UP-REGULATION PROMOTES AML STEM CELL PROPAGATION AND IS MIMICKED BY AGEING
Por: Xiying Ren, et al.
Publicado em: (2023-08-01)

ENL mutation and AML: a new model that reveals oncogenic condensate's function in leukemogenesis
Por: Zhong Fan, et al.
Publicado em: (2025-01-01)

Cellular Metabolomics Profiles Associated With Drug Chemosensitivity in AML
Por: Bradley Stockard, et al.
Publicado em: (2021-06-01)

In vitro transformation of primary human CD34+ cells by AML fusion oncogenes: early gene expression profiling reveals possible drug target in AML.
Por: Anmaar M Abdul-Nabi, et al.
Publicado em: (2010-08-01)

S119: CEBPA AND TET2 MUTATIONS COOPERATE TO INDUCE AGGRESSIVE AML VIA GATA-2 DOWNREGULATION
Por: E. Heyes, et al.
Publicado em: (2022-06-01)

Aberrant Bone Homeostasis in AML Is Associated with Activated Oncogenic FLT3-Dependent Cytokine Networks
Por: Isabel Bär, et al.
Publicado em: (2020-11-01)

Shift of N-MYC Oncogene Expression in AML Patients Carrying the FLT3-ITD Mutation
Por: Konstantin Bogdanov, et al.
Publicado em: (2023-08-01)

Tafazzin modulates cellular phospholipid composition to regulate AML stemness
Por: Ayesh K. Seneviratne, et al.
Publicado em: (2019-09-01)

Germline RUNX1 Intragenic Deletion: Implications for Accurate Diagnosis of FPD/AML
Por: Nicolas Duployez, et al.
Publicado em: (2019-06-01)

Inflammation-induced cellular changes: Genetic mutations, oncogene impact, and novel glycoprotein biomarkers
Por: Xiaotong Wang, et al.
Publicado em: (2024-01-01)

Delineating the cellular pathways and molecular determinants of normal and leukemic hematopoiesis
Por: Jacobsen, SE
Publicado em: (2009)

Investigation of oncogenic cooperation in simple liver-specific transgenic mouse models using noninvasive in vivo imaging.
Por: Hye-Lim Ju, et al.
Publicado em: (2013-01-01)

AKT1E¹⁷K Is Oncogenic in Mouse Lung and Cooperates with Chemical Carcinogens in Inducing Lung Cancer.
Por: Donatella Malanga, et al.
Publicado em: (2016-01-01)

The molecular and cellular basis for oncogene collaboration in acute myeloid leukaemia
Por: Di Genua, C
Publicado em: (2018)

Impact of TP53 mutation on genetic and cellular hierarchy profile in complex karyotype AML/MDS with increased blasts
Por: Jinha Hwang, et al.
Publicado em: (2024-11-01)

FLT3-ITD INDUCED MYELOPROLIFERATION CAUSES A CELL EXTRINSIC DEPLETION OF HAEMATOPOIETIC STEM CELLS
Por: Mead, A, et al.
Publicado em: (2014)

KRAS (G12D) Cooperates with AML1/ETO to Initiate a Mouse Model Mimicking Human Acute Myeloid Leukemia
Por: Shanmin Zhao, et al.
Publicado em: (2014-01-01)

The Oncogenic Signaling Disruptor, NDRG1: Molecular and Cellular Mechanisms of Activity
Por: Jason Chekmarev, et al.
Publicado em: (2021-09-01)

Multi-stage Friend murine erythroleukemia: molecular insights into oncogenic cooperation
Por: Moreau-Gachelin Françoise
Publicado em: (2008-11-01)

Multiplexed single‐cell mass cytometry reveals distinct inhibitory effects on intracellular phosphoproteins by midostaurin in combination with chemotherapy in AML cells
Por: Emma Rörby, et al.
Publicado em: (2021-02-01)

Autophagic activity dictates the cellular response to oncogenic RAS.
Por: Wang, Y, et al.
Publicado em: (2012)

Editorial: Oncogenic RAS-Dependent Reprogramming of Cellular Plasticity
Por: Georgia Konstantinidou, et al.
Publicado em: (2020-04-01)

ZNF768 links oncogenic RAS to cellular senescence
Por: Romain Villot, et al.
Publicado em: (2021-08-01)

Cell-Intrinsic Depletion of AML1-ETO-Positive Pre-Leukemic HSCs By Kras Activating Mutation
Por: Di Genua, C, et al.
Publicado em: (2017)

Genetic modelling of PIM proteins in cancer: proviral tagging, cooperation with oncogenes, tumor suppressor genes and carcinogens.
Por: Enara eAguirre, et al.
Publicado em: (2014-05-01)

Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in Mouse Models of Triple-Negative Breast Cancer
Por: Murphy, Charles J., et al.
Publicado em: (2019)

Differential Analysis of Genetic, Epigenetic, and Cytogenetic Abnormalities in AML
Por: Islam, M., et al.
Publicado em: (2017)

Differential Analysis of Genetic, Epigenetic, and Cytogenetic Abnormalities in AML
Por: Mirazul Islam, et al.
Publicado em: (2017-01-01)

The acute myeloid leukemia associated AML1-ETO fusion protein alters the transcriptome and cellular progression in a single-oncogene expressing in vitro induced pluripotent stem cell based granulocyte differentiation model.
Por: Esther Tijchon, et al.
Publicado em: (2019-01-01)

Molecular characterization of the chromosome 9q deletion in AML.
Por: Side, L, et al.
Publicado em: (2000)

IDH1 as a Cooperating Mutation in AML Arising in the Context of Shwachman-Diamond Syndrome
Por: Stéphanie Mourad, et al.
Publicado em: (2019-08-01)